As MTDH promotes a therapy-resistant, mesenchymal-high cell state, we therefore focused on whether MTDH enhances the vulnerability of cancer cells to ferroptosis inducers and the mechanism of the underlying vulnerability. Here, MTDH is linked to cancer.